Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
Posted on AllSides December 1st, 2023
From The Center
Drugmaker Novo Nordisk paid U.S. medical professionals at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs, a Reuters analysis found. It concentrated that money on an elite group of obesity specialists who advocate giving its powerful and expensive drugs to tens of millions of Americans.
AllSides Media Bias Rating: Center
